Depression care has changed in recent years. For people who have not improved with standard medication, transcranial magnetic stimulation, or TMS, is now part of the treatment conversation in Australia.
TMS uses magnetic pulses to stimulate areas of the brain involved in mood. It does not require surgery, anaesthetic or a hospital stay, which is one reason it attracts attention as a newer option.
In Australia, Medicare funding for eligible patients has been available since 1 November 2021 under specific rTMS items for major depressive episodes that have not responded to adequate antidepressant treatment.
What is TMS therapy?
- TMS is a clinic-based treatment delivered while the patient is awake and seated.
- A coil is placed against the scalp, and brief magnetic pulses are directed to a targeted part of the brain.
- Sessions are usually repeated across several weeks rather than given as a one-off treatment.
- The Royal Australian and New Zealand College of Psychiatrists describes repetitive TMS as an effective treatment for major depressive disorders and notes that it has a strong evidence base in depression care.
- As TMS is a non-invasive depression treatment, it does not involve sedation, theatre time or recovery in hospital. Sydney clinics also categorise it as an outpatient procedure, with people generally able to return to normal daily activities after each appointment.
Why are more people in Sydney considering new treatments for depression?
Part of the answer is simple: many people do not get enough relief from first-line treatment. rTMS focuses on adults whose depression has not improved after adequate trials of at least two classes of antidepressants, under psychiatrist-led care.
Some patients struggle with medication side effects. Others improve only partially, then relapse. That does not mean antidepressants have failed as a whole, nor does it mean TMS is suitable for everyone. It means depression treatment is becoming more flexible, with room for another evidence-based option when standard care has not been enough.
TMS vs. Antidepressants: What is the difference?
TMS is not a replacement for medication in every case, and antidepressants are not automatically the better first choice for every patient. They work in different ways and suit different clinical situations.
A practical comparison looks like this:
- How they work: Antidepressants act through chemical pathways, while TMS stimulates brain regions linked with mood using magnetic pulses.
- Where treatment happens: Medication is taken at home; TMS is delivered in a supervised clinic setting.
- Side effects: Antidepressants may cause body-wide side effects, while common TMS side effects are usually local and short-lived, such as scalp discomfort or headache.
- Time commitment: Antidepressants are taken daily, while an initial Medicare-supported TMS course can include up to 30 sessions.
TMS asks more of a person’s schedule, but it may appeal to those who want a non-drug option within specialist care.
Who may benefit from TMS therapy?
The clearest group is adults with a major depressive episode that has not improved after standard antidepressant treatment.
It may be considered for people who:
- Have had little to no benefit from other medications
- Want to discuss non-drug options with a psychiatrist
- Can attend regular clinic sessions over several weeks
- Are suitable for rTMS after clinical assessment
Also Read: Burned Out on Meds? Why More People Are Turning to TMS for Depression
What happens at a Sydney TMS clinic?
The process is usually straightforward. In Sydney, referral pathways commonly begin with a GP or psychiatrist referral, followed by assessment for suitability, safety and funding eligibility. Patients need a GP or psychiatrist referral.
A typical pathway may include:
- Review of diagnosis and treatment history
- Discussion of medicare criteria and costs
- Psychiatrist assessment and treatment planning
- A course of outpatient sessions over several weeks.
Is TMS therapy the future of depression treatment?
TMS is unlikely to replace every existing treatment. That is not really the point. Its value lies in widening the set of evidence-based options available to people with depression, especially those who have not responded well to standard medication. In that sense, TMS therapy is already part of the future of depression care in Australia. It offers another path, and for some patients that can make a genuine difference.
Frequently Asked Questions:
1. Is TMS therapy covered by Medicare in 2026?
Yes, for eligible patients. The relevant Medicare items remain listed for rTMS treatment of major depressive episodes, but access depends on meeting strict criteria, including age, diagnosis, antidepressant history and psychiatrist-led care.
2. Do I need a GP referral for TMS in Sydney?
Yes, a GP or psychiatrist referral is required to avail TMS treatment in Sydney.
3. How many sessions of TMS are needed for depression?
An initial Medicare-supported course can include up to 30 sessions. The exact number depends on the treatment plan, clinical response and psychiatrist review during the course.
4. What are the side effects of TMS therapy?
Common side effects include headache, scalp discomfort and facial muscle twitching during stimulation. These effects are usually mild and often ease as treatment continues.
5. Can I drive after a TMS treatment session?
In most cases, yes. Because no anaesthetic or sedative is used, patients can generally return to normal activities, including driving, after treatment.
Medical Disclaimer: This article is for general information only and does not constitute medical advice, diagnosis or treatment. Always seek advice from a qualified doctor or psychiatrist regarding your symptoms, treatment options and suitability for TMS.
